Is a treat-to-target approach to lipid-lowering therapy appropriate in patients with chronic kidney disease? A prospective French cohort study. Massy ZA, Kolla E, Ferrieres J, Bruckert E, et al. J Nephrol 2021 Jun 11. pii: 10.1007/s40620-021-01086.

Read + Share

Amedeo Smart

Independent Medical Education